BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34102975)

  • 1. 123I-Ioflupane SPECT and 18F-FDG PET Combined Use in the Characterization of Movement and Cognitive Associated Disorders in Neurodegenerative Diseases.
    Nuvoli S; Tanda G; Stazza ML; Palumbo B; Frantellizzi V; De Vincentis G; Spanu A; Madeddu G
    Curr Alzheimer Res; 2021; 18(3):196-207. PubMed ID: 34102975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Qualitative and Quantitative Analyses of Brain 18Fluoro-Deoxy-Glucose Positron Emission Tomography in Primary Progressive Aphasia.
    Nuvoli S; Tanda G; Stazza ML; Madeddu G; Spanu A
    Dement Geriatr Cogn Disord; 2019; 48(5-6):250-260. PubMed ID: 32062656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complementary role of 18F-FDG PET and 123I-ioflupane SPECT in the diagnosis of Lewy body disease.
    Jolepalem P; Balon HR; Wong CY; Wu D
    J Nucl Med Technol; 2014 Sep; 42(3):233-4. PubMed ID: 25033885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 123I-ioflupane brain SPECT and 123I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders.
    Nuvoli S; Spanu A; Piras MR; Nieddu A; Mulas A; Rocchitta G; Galleri G; Serra PA; Madeddu G
    Medicine (Baltimore); 2017 May; 96(21):e6967. PubMed ID: 28538394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concordance between (99m)Tc-ECD SPECT and 18F-FDG PET interpretations in patients with cognitive disorders diagnosed according to NIA-AA criteria.
    Ito K; Shimano Y; Imabayashi E; Nakata Y; Omachi Y; Sato N; Arima K; Matsuda H
    Int J Geriatr Psychiatry; 2014 Oct; 29(10):1079-86. PubMed ID: 24687634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].
    Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla J; Portilla-Quattrociocchi H; Medina-Quiroz P; Ortega F; Rodríguez E; Mateo I; Vázquez-Higuera JL; de Arcocha M; Carril JM
    Rev Esp Med Nucl; 2011; 30(5):301-6. PubMed ID: 21640440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral Glucose Metabolism and Dopaminergic Function in Patients with Corticobasal Syndrome.
    Mille E; Levin J; Brendel M; Zach C; Barthel H; Sabri O; Bötzel K; Bartenstein P; Danek A; Rominger A
    J Neuroimaging; 2017 Mar; 27(2):255-261. PubMed ID: 27572945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 123I-ioflupane SPECT in Fahr disease.
    Paghera B; Caobelli F; Giubbini R
    J Neuroimaging; 2013 Jan; 23(1):157-8. PubMed ID: 21410813
    [No Abstract]   [Full Text] [Related]  

  • 9. Low efficacy of 18F-FDG PET for detection of uveal malignant melanoma compared with 123I-IMP SPECT.
    Kato K; Kubota T; Ikeda M; Tadokoro M; Abe S; Nakano S; Nishino M; Kobayashi H; Ishigaki T
    J Nucl Med; 2006 Mar; 47(3):404-9. PubMed ID: 16513608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-carotid endarterectomy changes in cerebral glucose metabolism on (18)F-fluorodeoxyglucose positron emission tomography associated with postoperative improvement or impairment in cognitive function.
    Yoshida K; Ogasawara K; Saura H; Saito H; Kobayashi M; Yoshida K; Terasaki K; Fujiwara S; Ogawa A
    J Neurosurg; 2015 Dec; 123(6):1546-54. PubMed ID: 26230467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Undetectable specific striatal [¹²³I]-ioflupane binding in patients with parkinsonism.
    Petyt G; Kreisler A; Demailly F; Olivier A; Defebvre L; Semah F
    J Neurol Sci; 2014 Jun; 341(1-2):167-71. PubMed ID: 24814162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced 123I Ioflupane Binding in Bilateral Diabetic Chorea: Findings With 18F FDG PET, 99mTc ECD SPECT, and 123I MIBG Scintigraphy.
    Sato K; Hida A; Kameyama M; Morooka M; Takeuchi S
    Clin Nucl Med; 2016 Jun; 41(6):481-2. PubMed ID: 26975011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Performance of the Visual Reading of
    Booij J; Dubroff J; Pryma D; Yu J; Agarwal R; Lakhani P; Kuo PH
    J Nucl Med; 2017 Nov; 58(11):1821-1826. PubMed ID: 28473597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear medicine imaging in tuberculosis using commercially available radiopharmaceuticals.
    Sathekge M; Maes A; D'Asseler Y; Vorster M; Van de Wiele C
    Nucl Med Commun; 2012 Jun; 33(6):581-90. PubMed ID: 22422098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.
    Appel L; Jonasson M; Danfors T; Nyholm D; Askmark H; Lubberink M; Sörensen J
    J Nucl Med; 2015 Feb; 56(2):234-42. PubMed ID: 25593112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer's Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis.
    Khosravi M; Peter J; Wintering NA; Serruya M; Shamchi SP; Werner TJ; Alavi A; Newberg AB
    J Alzheimers Dis; 2019; 70(4):1197-1207. PubMed ID: 31322568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Advancement and Clinical Implications of 18FDG-PET in Parkinson's Disease, Atypical Parkinsonisms, and Other Movement Disorders.
    Peralta C; Biafore F; Depetris TS; Bastianello M
    Curr Neurol Neurosci Rep; 2019 Jun; 19(8):56. PubMed ID: 31256288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early differential diagnosis between Alzheimer's disease and dementia with Lewy bodies: Comparison between (18)F-FDG PET and (123)I-IMP SPECT.
    Chiba Y; Iseki E; Fujishiro H; Ota K; Kasanuki K; Suzuki M; Hirayasu Y; Arai H; Sato K
    Psychiatry Res Neuroimaging; 2016 Mar; 249():105-12. PubMed ID: 26857415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential 123I-iododexetimide scans in temporal lobe epilepsy: comparison with neuroimaging scans (MR imaging and 18F-FDG PET imaging).
    Mohamed A; Eberl S; Fulham MJ; Kassiou M; Zaman A; Henderson D; Beveridge S; Constable C; Lo SK
    Eur J Nucl Med Mol Imaging; 2005 Feb; 32(2):180-5. PubMed ID: 15449046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Negative predictive value of (123)I Ioflupane SPECT in movement disorders].
    Serrano Vicente J; García Bernardo L; Durán Barquero C; Constantino Silva A; Infante de la Torre JR; Domínguez Grande ML; Rayo Madrid JI; Sánchez Sánchez R; Durán Herrera C
    Rev Esp Med Nucl; 2009; 28(1):2-5. PubMed ID: 19232169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.